M05.75 Rheumatoid arthritis with rheumatoid factor of hip without organ or systems involvement

Name of the Condition

• Rheumatoid arthritis with rheumatoid factor of hip without organ or systems involvement

Summary

Rheumatoid arthritis (RA) is a chronic autoimmune disorder that causes inflammation in the joints. This specific code applies to cases where rheumatoid factor is present, and the condition is localized to the hip, with no involvement of other organs or systems. The condition is characterized by joint pain, swelling, and stiffness, typically affecting the hip joint symmetrically.

Causes

The exact cause of rheumatoid arthritis is unknown, but it is believed to result from a combination of genetic, environmental, and immune system factors. The presence of rheumatoid factor, an antibody that targets the body’s own tissues, is a key feature of this condition.

Risk Factors

• Age: Most commonly develops between 30 and 60 years.
• Gender: More prevalent in women.
• Genetics: Family history of RA increases risk.
• Smoking: Linked to higher severity and onset of the condition.

Symptoms

• Joint pain, tenderness, swelling, or stiffness affecting the hip.
• Morning stiffness lasting longer than 30 minutes.
• Fatigue and occasional low-grade fevers.
• Symmetrical joint involvement (both hips affected).

Diagnosis

Diagnosis involves a combination of clinical evaluation and laboratory tests. Blood tests detect rheumatoid factor and anti-citrullinated protein antibodies (ACPAs). Imaging studies, such as X-rays or MRIs, assess joint damage and inflammation in the hip. Clinical criteria, including joint involvement patterns and symptom duration, are also considered.

Treatment Options

Treatment focuses on reducing inflammation, relieving pain, and preserving joint function. Medications may include disease-modifying antirheumatic drugs (DMARDs), nonsteroidal anti-inflammatory drugs (NSAIDs), and corticosteroids. Physical therapy and lifestyle modifications, such as exercise and weight management, support mobility and overall health.

Prognosis and Follow-Up

Prognosis varies, but early diagnosis and treatment can improve outcomes. Regular follow-up with a rheumatologist is essential to monitor disease activity, adjust therapies, and address complications. Long-term management aims to minimize joint damage and maintain quality of life.

Complications

Untreated or poorly managed RA can lead to joint deformity, reduced mobility, and decreased function. Chronic inflammation may increase the risk of cardiovascular disease and osteoporosis. Hip involvement may result in significant disability if not addressed promptly.

Lifestyle & Prevention

Maintaining a healthy weight reduces stress on hip joints. Low-impact exercises, such as swimming or cycling, support joint flexibility and muscle strength. Avoiding smoking and managing stress may help reduce disease activity. A balanced diet rich in anti-inflammatory foods is also beneficial.

When to Seek Professional Help

Seek medical attention if you experience persistent hip pain, swelling, or stiffness lasting more than six weeks. Early evaluation is critical to prevent joint damage. Contact a healthcare provider immediately for sudden severe pain, inability to bear weight, or signs of infection (e.g., fever, redness).

Tips for Medical Coders

This code (M05.75) is specific to rheumatoid arthritis with rheumatoid factor affecting the hip, without organ or system involvement. Ensure documentation confirms hip joint involvement, rheumatoid factor positivity, and the absence of extra-articular manifestations. Code assignment should align with clinical findings and provider documentation.